ceptors for IL-2 as shown by the binding of both radiolabeled purified IL-2 and monoclonal antibodies to IL-2 receptors. In addition, it synthesizes IL-2, which is bound to cell surface receptors. Monoclonal antibodies directed against either IL-2 or the IL-2 receptor block IARC 301 cell growth. These findings demonstrate that the proliferation of this tumor cell line is mediated by an autocrine pathway involving endogenous IL-2 production and its binding to cell surface receptors.
Tumor cells often do not need growth factors that control normal cell division. Such observations suggest that growth factors might play an essential role in the development of malignancies. This hypothesis is supported by the evidence that some oncogenes code for growth factors or growth factor receptors (1) (2) (3) (4) .
Activation of an autocrine self-stimulation, whereby a cell both secretes and responds to a growth factor (5), may be of importance for the growth of some tumors and cell lines. This was first described for cells infected with transforming viruses, which secrete transforming growth factors able to support normal cell growth in soft agar and induce tumorigenicity of those cells (6) (7) (8) .
More recently, it has been reported that cells transformed with simian sarcoma virus synthesize a polypeptide, required for their growth, which is the product of the viral oncogene v-sis and exhibits biological activities of platelet-derived growth factor (PDGF) (9, 10) . Also an osteosarcoma cell line expresses PDGF receptors and produces a PDGF-like growth factor (11) . Finally, viral oncogenes of the src family can induce chicken myeloid cells to produce a chicken myelomonocytic-like growth factor that stimulates their proliferation (12) .
Interleukin 2 (IL-2) or T-cell growth factor (13, 14) , a glycoprotein of molecular weight 15,500, is released by T lymphocytes after stimulation by an antigen or a mitogen and allows the long-term growih in vitro of normal T cells (15, 16) .
It promotes the growth ofT lymphocytes through specific cell surface receptors that appear upon activation (17) and are expressed transiently after such a stimulation (18) . The gene coding for human IL-2 has been cloned (19) (20) (21) , and IL-2 can be purified either by recombinant DNA techniques or from the supernatant of activated human T cells.
Some human T-cell leukemia virus type I (HTLV-I)-transformed T-cell lines initially established in vitro in the presence of IL-2 have become independent of this factor, respond to IL-2, and synthesize it (22) , although most HTLV-I-transformed cell lines do not (23) . This suggests that IL-2 might stimulate growth of some tumor T-cell lines by an autocrine mechanism.
We have established a human T-cell line IARC 301 from the lymph nodes of a patient with a malignant lymphoma. This cell line, which has never been grown in the presence of IL-2, bears IL-2 receptors on its surface. In this work we asked whether an autocrine stimulation by IL-2 could be involved in IARC 301 cell growth.
We show that IARC 301 cells constitutively express high-affinity receptors for IL-2 to Which are bound IL-2 molecules that had been produced by these To inhibit IL-2 activity, purified DMS1 antibody was added together with 0.8 unit of IL-2 per ml at the beginning of the assay as described (24) .
IL-2 Binding Assay. The binding of radiolabeled IL-2 was performed by using published procedures (17) . In brief, the cells were incubated at 37°C and washed before the binding assay as described. Binding of IL-2 was then performed for 2 hr at 4°C. Nonspecific binding was determined by adding a 100-fold excess of unlabeled IL-2, either purified from the Jurkat supernatant or recombinant IL-2, and was <l1o of specific binding at all IL-2 concentrations in both cases.
Acid pH Elution of Cell Surface-Bound Proteins. Cell surface-bound proteins were eluted by published procedures (29) . In brief, 1. (Fig. 1) (Fig. 3) . Both proliferation, as measured by [ DMS1 (24) inhibited both the proliferation of CTLL-2 due to the material eluted from IARC 301 and the proliferation due to recombinant IL-2 (Fig. 4) , confirming that IL-2 is eluted from IARC 301 cell surface. It can be calculated from the results presented in Fig. 4 , that this would correspond to about 650 molecules of IL-2 bound per cell on exponentially growing IARC 301.
Anti-IL-2 Receptor Antibodies Inhibit UIRC 301 Growth. Since IARC 301 produces IL-2 and has on its surface functional IL-2 receptors, we wondered if in standard culture conditions (without addition of exogenous IL-2) IL-2 receptors are necessary for cell growth. It has been shown previously that the anti-IL-2 receptor antibody anti-Tac inhibits growth of IL-2-dependent T-cell lines (26) . The effect of anti-Tac antibody on IARC 301 proliferation was studied by adding anti-Tac antibody to IARC 301 cultures and by following cell growth. As shown in Table 2 , anti-Tac antibody inhibited IARC 301 proliferation, whereas an unrelated antibody of the same subclass and an anti-HLA antibody, W 6/32, which binds to IARC 301 cell surface as seen by immunofluorescence, at the same dilution of ascites fluid had little effect.
Inhibition of IARC 301 proliferation by anti-Tac establishes that functional IL-2 receptors are necessary for IARC 301 cells to grow.
Anti-IL-2 Antibodies Inhibit IARC 301 Growth. We next tested if IL-2 synthesized by IARC 301 is necessary for its growth. Anti-IL-2 antibody DMS1, partially purified by ammonium sulfate precipitation, was added to IARC 301 culture and [3H]thymidine incorporation was measured 2 days later. DMS1 added at a final concentration of 200 ,ug/ml inhibited >90% of the cell proliferation (Table 3) . A controlpurified IgG of the same subclass at the same concentration In a previous study, Gootenberg et al. (22) have shown that two HTLV-I-transformed T-cell lines, which had been established in vitro in the presence of IL-2 and which were adapted to grow in medium lacking this factor, produce IL-2 and proliferate in response to exogenous IL-2. Also, a gibbon ape cell line MLA-144 has been described that expresses IL-2 receptors and secretes . This suggests that these cells might autostimulate their growth. IARC 301 cells not only express IL-2 receptors and secrete IL-2, but also their growth is inhibited by monoclonal antibodies directed against IL-2 and IL-2 receptors; this directly demonstrates that an autocrine mechanism is involved in the growth of a tumor T cell. Some normal, activated T cells may also grow through an autocrine stimulation by IL-2. This is suggested by the recent work of Meuer et al. (35) who showed that two human T-cell clones, stimulated by anticlonotypic antibodies produce IL-2 and bear IL-2 receptors and that anti-IL-2 and anti-receptor antibodies partially inhibit their proliferation. Nevertheless, it does not necessarily follow that this is a general property of T cells involved in a normal immune response.
IL-2 receptors of normal T cells are expressed only after stimulation by an antigen, a mitogen, or anti-clonotypic antibodies, and their expression is transient and lasts no longer than a few cell divisions (18, 36, 37) . The regulation of IL-2 receptor expression may function as a fail-safe mechanism to prevent the uncontrolled growth of T cells. One difference between IARC 301 and the T-cell clones of Meuer et al. (35) is that the IL-2 receptor expression on IARC 301 does not seem to depend upon stimulation. This difference may be critical for IARC 301 permanent growth in vitro, and such a mechanism might be involved in some T-cell tumors.
IARC 301 presents a good experimental model to study the intracellular events due to an autocrine stimulation of growth by IL-2. Some of these events probably also play a role in IL-2 stimulation of normal T cells, and an understanding of these pathways should provide insights into the mechanism of regulation of T-cell growth.
